AU8743001A - Moraxella polypeptides and corresponding dna fragments and uses thereof - Google Patents

Moraxella polypeptides and corresponding dna fragments and uses thereof

Info

Publication number
AU8743001A
AU8743001A AU8743001A AU8743001A AU8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A AU 8743001 A AU8743001 A AU 8743001A
Authority
AU
Australia
Prior art keywords
dna fragments
corresponding dna
moraxella polypeptides
moraxella
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8743001A
Inventor
Loosmore Sheena
Wang Joe
Bradley Bill
Ochs Martina
Yang Yan-Ping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU8743001A publication Critical patent/AU8743001A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
AU8743001A 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof Pending AU8743001A (en)

Applications Claiming Priority (28)

Application Number Priority Date Filing Date Title
US22829600P 2000-08-28 2000-08-28
US22829400P 2000-08-28 2000-08-28
US22829500P 2000-08-28 2000-08-28
US22851100P 2000-08-29 2000-08-29
US22843900P 2000-08-29 2000-08-29
US22877300P 2000-08-29 2000-08-29
US22844300P 2000-08-29 2000-08-29
US22844000P 2000-08-29 2000-08-29
US22843800P 2000-08-29 2000-08-29
US22874200P 2000-08-29 2000-08-29
US22844100P 2000-08-29 2000-08-29
US22844200P 2000-08-29 2000-08-29
US22851200P 2000-08-29 2000-08-29
US22946500P 2000-09-01 2000-09-01
US22947800P 2000-09-01 2000-09-01
US22947500P 2000-09-01 2000-09-01
US22947400P 2000-09-01 2000-09-01
US22974000P 2000-09-05 2000-09-05
US22980900P 2000-09-05 2000-09-05
US22980300P 2000-09-05 2000-09-05
US22980400P 2000-09-05 2000-09-05
US22980500P 2000-09-05 2000-09-05
US22981100P 2000-09-05 2000-09-05
US22980600P 2000-09-05 2000-09-05
US23025000P 2000-09-06 2000-09-06
US23025200P 2000-09-06 2000-09-06
US23021400P 2000-09-06 2000-09-06
PCT/CA2001/001221 WO2002018595A2 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU8743001A true AU8743001A (en) 2002-03-13

Family

ID=27586817

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8743001A Pending AU8743001A (en) 2000-08-28 2001-08-24 Moraxella polypeptides and corresponding dna fragments and uses thereof
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001287430A Abandoned AU2001287430A1 (en) 2000-08-28 2001-08-28 Moraxella polypeptides and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (2) AU8743001A (en)
WO (1) WO2002018595A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092625A2 (en) * 2001-05-15 2002-11-21 Shire Biochem Inc. Moraxella(branhamella) catarrhalis antigens
AU2002342466A1 (en) 2001-11-16 2003-06-10 Id Biomedical Corporation Polypeptides of moraxella (branhamella) catarrhalis
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
JP2008504292A (en) 2004-06-24 2008-02-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Immune enhancement compounds
JP2009511636A (en) 2005-10-18 2009-03-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Mucosal and systemic immunity with alphavirus replicon particles
JP5215865B2 (en) 2005-11-22 2013-06-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド Norovirus and sapovirus antigens
US20090317421A1 (en) 2006-01-18 2009-12-24 Dominique Missiakas Compositions and methods related to staphylococcal bacterium proteins
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
RU2471497C2 (en) 2007-09-12 2013-01-10 Новартис Аг Mutant antigens gas57 and gas57 antibodies
WO2009081274A2 (en) 2007-12-21 2009-07-02 Novartis Ag Mutant forms of streptolysin o
US8466167B2 (en) 2008-03-03 2013-06-18 Irm Llc Compounds and compositions as TLR activity modulators
CA2749367A1 (en) 2009-01-12 2010-07-15 Novartis Ag Cna_b domain antigens in vaccines against gram positive bacteria
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
EP2443250B8 (en) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
ES2443952T3 (en) 2009-09-02 2014-02-21 Novartis Ag Immunogenic compositions that include modulators of TLR activity
JO3257B1 (en) 2009-09-02 2018-09-16 Novartis Ag Compounds and compositions as tlr activity modulators
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
EP2549990A1 (en) 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
CN102933267B (en) 2010-05-28 2015-05-27 泰特里斯在线公司 Interactive hybrid asynchronous computer game infrastructure
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
GB201102091D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
GB201102090D0 (en) * 2011-02-08 2011-03-23 Univ Sheffield Antigenic polypeptide
CN105188747A (en) 2013-02-01 2015-12-23 葛兰素史密斯克莱生物公司 Intradermal delivery of immunological compositions comprising TOLL-like receptor agonists
US11458151B2 (en) 2018-02-12 2022-10-04 Inimmune Corporation Toll-like receptor ligands
CA3198924A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Phage-derived particles for in situ delivery of dna payload into c. acnes population

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6541616B1 (en) * 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
CA2378687A1 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
GB9921691D0 (en) * 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Also Published As

Publication number Publication date
AU2001287430A8 (en) 2002-03-13
WO2002018595A9 (en) 2007-08-23
AU2001287430A1 (en) 2002-03-13
WO2002018595A3 (en) 2002-10-03
WO2002018595A2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2001287430A8 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
EP1568773A2 (en) Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (en) Novel nucleic acids and polypeptides
EP1504099A4 (en) Novel nucleic acids and polypeptides
EP1432800A4 (en) Novel nucleic acids and polypeptides
EP1470238A4 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
EP1341804A4 (en) Novel nucleic acids and polypeptides
EP1430112A4 (en) Novel nucleic acids and polypeptides
HUP0500989A2 (en) Animicrobial polypeptides and their uses
EP1276751A4 (en) Novel nucleic acids and polypeptides
EP1368475A4 (en) Novel nucleic acids and polypeptides
EP1141301A4 (en) Sequence-determined dna fragments and corresponding polypeptides encoded thereby
EP1357186A4 (en) Novel proteins and dnas thereof
EP1341803A4 (en) Novel nucleic acids and polypeptides
EP1293568A4 (en) Novel protein and dna thereof
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
EP1293510A4 (en) Novel polypeptide and its dna
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (en) Novel nucleic acids and polypeptides
IL161765A0 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
EP1274716A4 (en) Novel nucleic acids and polypeptides
AU7005801A (en) Gp354 nucleic acids and polypeptides